Search

Displaying results 9431 - 9440 of 10000 in total
  1. Drug

    Dazostinag

    go.drugbank.com/drugs/DB18889
    Investigational

    Dazostinag is under investigation in clinical trial NCT04420884 (A Study of Dazostinag as Single Agent and Dazostinag in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors

    Synonyms: 7-Deazainosine, [P(R)]-2′-deoxy-2′-fluoro-5′-O-[(R)-hydroxymercaptophosphinyl]-P-thioadenylyl-(3′→5′)-7-fluoro-, cyclic (2′→5′)-nucleotide
  2. Drug

    beta-D-glucuronic acid

    go.drugbank.com/drugs/DB03156
    Investigational

    Mixtures: Hygienium Hand Sanitizer wipes
  3. Drug

    MK-8666

    go.drugbank.com/drugs/DB14937
    Investigational

    MK-8666 is under investigation in clinical trial NCT01971554 (Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of MK-8666 in Participants With Type 2 Diabetes Mellitus (MK-8666-003)).

  4. Drug

    Rasdegafusp alfa

    go.drugbank.com/drugs/DB15185
    Investigational

    Rasdegafusp alfa is under investigation in clinical trial NCT03206047 (Atezolizumab, Guadecitabine, and CDX-1401 Vaccine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal

  5. Drug

    VIS-410

    go.drugbank.com/drugs/DB19067
    Investigational

    VIS-410 is under investigation in clinical trial NCT03040141 (Study of Efficacy and Safety of IV VIS410 Plus Oseltamivir Versus Oseltamivir in Hospitalized Adults With Influenza A).

  6. Drug

    VV-14300

    go.drugbank.com/drugs/DB33996
    Experimental

    VV-14300 is under investigation in clinical trial NCT07829302 (VV-14299 and VV-14300 for the Treatment of Type 1 Diabetes).

  7. Drug

    VV-14299

    go.drugbank.com/drugs/DB33997
    Experimental

    VV-14299 is under investigation in clinical trial NCT07829302 (VV-14299 and VV-14300 for the Treatment of Type 1 Diabetes).

  8. Drug

    PR1 leukemia peptide vaccine

    go.drugbank.com/drugs/DB15276
    Investigational

    PR1 leukemia peptide vaccine is under investigation in clinical trial NCT00513578 (Vaccine Therapy and GM-CSF in Treating Patients With Low-Risk or Intermediate-Risk Myelodysplastic Syndrome).

  9. Drug

    Plinabulin

    go.drugbank.com/drugs/DB05992
    Investigational

  10. Drug

    Alnus glutinosa

    go.drugbank.com/drugs/DB15904
    Experimental

    Categories: Non-Standardized Plant Allergenic Extract